Treatment with a JQ1 inhibitor improves mitochondrial and heart function in a Pink1-dependent way and prevents HFD-induced DCM, supporting BRD4 inhibition as a valuable strategy for DCM treatment [61]. The gene discussed is PINK1; the disease is familial dilated cardiomyopathy.